Satlin A - Search Results

1

In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.

Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF. Frederick BD, et al. Among authors: satlin a. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1313-22. doi: 10.1016/j.pnpbp.2004.08.013. Prog Neuropsychopharmacol Biol Psychiatry. 2004. PMID: 15588758

2

Brain proton magnetic resonance spectroscopy in Alzheimer disease: changes after treatment with xanomeline.

Frederick Bd, Satlin A, Wald LL, Hennen J, Bodick N, Renshaw PF. Frederick Bd, et al. Among authors: satlin a. Am J Geriatr Psychiatry. 2002 Jan-Feb;10(1):81-8. Am J Geriatr Psychiatry. 2002. PMID: 11790638 Clinical Trial.

3

Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist.

Satlin A, Bodick N, Offen WW, Renshaw PF. Satlin A, et al. Am J Psychiatry. 1997 Oct;154(10):1459-61. doi: 10.1176/ajp.154.10.1459. Am J Psychiatry. 1997. PMID: 9326834 Clinical Trial.

4

Regional atrophy of the corpus callosum in subjects with Alzheimer's disease and multi-infarct dementia.

Lyoo IK, Satlin A, Lee CK, Renshaw PF. Lyoo IK, et al. Among authors: satlin a. Psychiatry Res. 1997 May 16;74(2):63-72. doi: 10.1016/s0925-4927(97)00009-7. Psychiatry Res. 1997. PMID: 9204509

5

In vivo proton magnetic resonance spectroscopy of Alzheimer's disease in the parietal and temporal lobes.

Frederick BB, Satlin A, Yurgelun-Todd DA, Renshaw PF. Frederick BB, et al. Among authors: satlin a. Biol Psychiatry. 1997 Jul 15;42(2):147-50. doi: 10.1016/s0006-3223(97)00242-4. Biol Psychiatry. 1997. PMID: 9209733 Clinical Trial. No abstract available.

6

Psychosis of Alzheimer's disease: Gender differences in regional perfusion.

Moran EK, Becker JA, Satlin A, Lyoo IK, Fischman AJ, Johnson KA. Moran EK, et al. Among authors: satlin a. Neurobiol Aging. 2008 Aug;29(8):1218-25. doi: 10.1016/j.neurobiolaging.2007.02.024. Epub 2007 Apr 3. Neurobiol Aging. 2008. PMID: 17408808

7

S-adenosyl-L-methionine in the treatment of Alzheimer's disease.

Cohen BM, Satlin A, Zubenko GS. Cohen BM, et al. Among authors: satlin a. J Clin Psychopharmacol. 1988 Feb;8(1):43-7. J Clin Psychopharmacol. 1988. PMID: 3350998

8

Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease.

Harris GJ, Lewis RF, Satlin A, English CD, Scott TM, Yurgelun-Todd DA, Renshaw PF. Harris GJ, et al. Among authors: satlin a. Am J Psychiatry. 1996 May;153(5):721-4. doi: 10.1176/ajp.153.5.721. Am J Psychiatry. 1996. PMID: 8615424

9

Regional cerebral blood volume measured by dynamic susceptibility contrast MR imaging in Alzheimer's disease: a principal components analysis.

Maas LC, Harris GJ, Satlin A, English CD, Lewis RF, Renshaw PF. Maas LC, et al. Among authors: satlin a. J Magn Reson Imaging. 1997 Jan-Feb;7(1):215-9. doi: 10.1002/jmri.1880070133. J Magn Reson Imaging. 1997. PMID: 9039618 Clinical Trial.

10

Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine.

Harris GJ, Lewis RF, Satlin A, English CD, Scott TM, Yurgelun-Todd DA, Renshaw PF. Harris GJ, et al. Among authors: satlin a. AJNR Am J Neuroradiol. 1998 Oct;19(9):1727-32. AJNR Am J Neuroradiol. 1998. PMID: 9802497 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters